Our findings highlight the emergence of autoreactive CD19– PCs as a critical feature of lupus pathogenesis in mice and underscore the need for therapeutic approaches that extend beyond CD19-targeting to improve treatment strategies in SLE. Here, CD19 is linked to systemic lupus erythematosus.